Skip to Content

Biometric Bracelet Lets a Medical Device Recognize its Wearer

A device that measures its wearer’s unique electric impedance could make medical procedures more convenient.
August 8, 2012

A device that measures someone’s unique response to a weak electric signal could let medical devices such as blood-pressure cuffs automatically identify the wearer and send measurements straight to his or her electronic medical record.

For now, nurses, patients, and doctors juggle the job of keeping patients’ identities straight. But computer scientist Cory Cornelius at Dartmouth College, in New Hampshire, has developed a wristwatch-like device that measures a person’s “bioimpedance” to identify him or her to medical monitoring devices.

Cornelius and colleagues presented a prototype sensor at the Usenix Advanced Computing System Association workshop in Bellevue, Washington, on Monday. Individual impedance varies because each person’s wrist, for example, is a unique jumble of bone, flesh, and blood vessels.

As medical instruments and implants become more computerized and connected, security and authentication are becoming an issue. A number of researchers have shown that medical devices are vulnerable to hacking (see “Personal Security”).

“The idea of using bioimpedance as a biometric is clever,” says computer scientist Kevin Fu, of the University of Massachusetts Amherst, who studies medical-device security (see “Kevin Fu, TR35 Innovator of the Year”).

Authenticating users of medical devices could have various practical benefits. A household might share an exercise-monitoring device, for example, and authentication would match household members with their own results.

“We did some initial tests on ourselves,” Cornelius says, but eventually the team scaled up the experiment to include 46 volunteers. One electrode on the device sends an alternating current through its wearer’s wrist to a second electrode. While the current is passing through the wrist, the electrodes detect the wrist’s resistance and reactivity, which are components of impedance. A processor extracted seven features from the electrode pattern, and the team then used a series of five readings per user to train the processor to recognize a given user’s bioimpedance profile.

The team took 80 more impedance measurements from each subject and compared them to the composite profiles created to test the device’s ability to recognize individuals. They found that if they subdivided the pool of 46 volunteers into family-sized groups of two to five, they could correctly identify the user 80 to 90 percent of the time. Combining the bioimpedance data with a simple wrist-circumference measurement improves accuracy by a couple of percentage points.

Ari Juels, chief scientist at RSA Laboratories in Cambridge, Massachusetts, is skeptical that bioimpedance can serve as a practical biometric. “The false acceptance and false rejection rates are considerably weaker than required for any likely security scenario,” he says. Fingerprint recognition must allow less than one acceptance in 1,000 to be false, he notes, and other signals such as electrocardiograms may offer more reliable passive biometrics.

Keep Reading

Most Popular

open sourcing language models concept
open sourcing language models concept

Meta has built a massive new language AI—and it’s giving it away for free

Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at with a list of newsletters you’d like to receive.